Skip to main content

Find Clinical Trials

Home
Conditions
Infant, Newborn, Diseases

Clinical trial condition

Infant, Newborn, Diseases

Explore clinical trials studying Infant, Newborn, Diseases. Study availability and eligibility vary by location and protocol.

2,533 public trials 318 recruiting studies

Refine in advanced search Browse all conditions

Infant, Newborn, Diseases trial results

Completed

Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease

NCT02390219

Conditions: Advanced Lung Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, +6 more
Locations: Denver, Colorado, United States

Tampa, Florida, United States

Chicago, Illinois, United States

St Louis, Missouri, United States

View Trial Details

Completed

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders

NCT01626092

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +50 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants

NCT00931632

Conditions: Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +5 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

Loma Linda University School of Medicine Loma Linda, California, United States

Children's Hospital of Orange County Orange, California, United States

View all 33 locations

View Trial Details

Completed

Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)

NCT00889434

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Hadassah Medical Organization, Mount Scopus Jerusalem, Israel

View Trial Details

Completed

Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis

NCT03357913

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
Locations: Service de médecine interne Centre Hospitalier Lyon Sud, Hospices Civils de Lyon Pierre-Bénite, France

View Trial Details

Completed

Adjustable Fortification of Human Milk Fed to Chinese Preterm Infants

NCT01731613

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse Sequences

NCT02449785

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: University Hospital Bordeaux Pessac, France

View Trial Details

Completed

Buprenorphine Dose Adjustments and Gestational Age

NCT03028883

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate GLPG2222 in Ivacaftor-treated Subjects With Cystic Fibrosis

NCT03045523

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: The Prince Charles Hospital Chermside, Australia

The Alfred Melbourne, Australia

Sir Charles Gairdner Hospital Nedlands, Australia

Westmead Hospital Westmead, Australia

View all 22 locations

View Trial Details

Completed

28 Day Repeat Dose in Cystic Fibrosis Patients

NCT00903201

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Palo Alto, California, United States

GSK Investigational Site Denver, Colorado, United States

View all 33 locations

View Trial Details